Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Bellerophon Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q3 2021
- Shares held
- 1.23M
- +48.4K (+4.1%) vs. Q3 2021
- Total value
- $3.82M
- −$986.0K (−20.5%) vs. Q3 2021
- New holders
- 5
- 7 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 90 | $0 | 0.00% | +16+21.6% | Added |
| Federated Hermes, Inc. | 164 | $1.00K | 0.00% | +164 | New |
| Northwestern Mutual Wealth Management Co | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 698 | $2.00K | 0.00% | +698 | New |
| Advisor Group Holdings, Inc. | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,221 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,220 | $7.00K | 0.00% | +1,049+89.6% | Added |
| Royal Bank of Canada | 2,429 | $7.00K | 0.00% | +2,255+1,296.0% | Added |
| Morgan Stanley | 5,487 | $17.0K | 0.00% | +3,664+201.0% | Added |
| Two Sigma Securities, LLC | 11,161 | $35.0K | 0.01% | +11,161 | New |
| Tudor Investment Corp Et Al | 20,000 | $62.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,327 | $66.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 24,134 | $75.0K | 0.00% | +24,134 | New |
| Northern Trust Corp | 36,410 | $113.0K | 0.00% | −243−0.7% | Reduced |
| Geode Capital Management, LLC | 58,350 | $180.0K | 0.00% | −250.0% | Reduced |
| Jane Street Group, LLC | 74,060 | $230.0K | 0.00% | +74,060 | New |
| Telemetry Investments, L.L.C. | 102,781 | $319.0K | 0.42% | +17,281+20.2% | Added |
| BlackRock Inc. | 121,670 | $378.0K | 0.00% | +1,050+0.9% | Added |
| Renaissance Technologies LLC | 178,899 | $555.0K | 0.00% | −22,807−11.3% | Reduced |
| Wells Fargo & Company | 200,052 | $620.0K | 0.00% | −50,000−20.0% | Reduced |
| Vanguard Group Inc | 370,553 | $1.15M | 0.00% | +29,098+8.5% | Added |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,879−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| Professional Financial Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −241−100.0% | Sold out |